Search | Schedule | Concurrent Oral Session Grid | Author Index | eBook | Personal Scheduler

Swapnil Rajpathak, MD

Outcomes Research Scientist/Director
Merck
One Merck Drive
Whitehouse, NJ
USA 08889


Papers:

  • USE OF SULFONYLUREAS IS ASSOCIATED WITH HIGHER RISK OF READMISSION AMONG PATIENTS WITH TYPE 2 DIABETES